Checkmate Pharmaceuticals inks $85m Series C

Cambridge, Massachusetts-based Checkmate Pharmaceuticals, a clinical stage biotechnology company, has closed $85 million in Series C financing.

Cambridge, Massachusetts-based Checkmate Pharmaceuticals, a clinical stage biotechnology company, has closed $85 million in Series C financing. Longitude Capital and Novo Holdings led the round.

Source: Press Release